US Physical Therapy (USPH) 15th Annual Midwest IDEAS Investor Conference summary
Event summary combining transcript, slides, and related documents.
15th Annual Midwest IDEAS Investor Conference summary
23 Jan, 2026Business model and growth strategy
Operates nearly 700 outpatient orthopedic physical therapy facilities across 42 states, using a partnership model where local partners retain about 30% equity and their own brands.
Grows through both organic expansion (adding 25–30 new facilities annually) and selective acquisitions, focusing on high-quality providers rather than distressed assets.
Acquisitions maintain local brands to avoid community disruption and leverage established reputations.
Partners manage local care and relationships, while centralized support handles back-office functions, compliance, and growth initiatives.
Clinics are capital efficient, with startup costs of $170,000–$180,000 and payback within three years.
Market dynamics and competitive landscape
The U.S. physical therapy market is estimated at $30–$40 billion, with about 37,000 clinics and no single provider holding more than 10% market share.
Market remains highly fragmented, with consolidation ongoing but significant runway remaining.
Company is seen as a high-integrity consolidator, offering long-term stability compared to private equity buyers.
Expansion into states like California and New York is now possible due to changing regulations and market conditions.
Financial performance and capital structure
Maintains a strong balance sheet with over $100 million in cash, $140 million in fixed, hedged borrowings, and a $175 million credit facility.
Cash flow is robust, supporting both growth and a dividend (currently about 2% yield, paid since 2011/2012).
Blended acquisition multiples average 7–7.5x EBITDA; clinics generate strong cash flow and high returns on invested capital.
Minimal net debt and disciplined capital deployment have enabled hundreds of millions in growth investment.
Latest events from US Physical Therapy
- Record 2025 growth and new alliances position for higher 2026 EBITDA and continued expansion.USPH
Q4 20259 Mar 2026 - Double-digit growth and high-margin expansion in injury prevention drive strong performance.USPH
16th Annual Midwest Ideas Conference3 Feb 2026 - Record patient volumes and IIP growth drove revenue up, but margins and EPS declined.USPH
Q2 20241 Feb 2026 - Record patient volumes, 12% revenue growth, and major acquisitions drive future expansion.USPH
Q3 202416 Jan 2026 - Growth through strategic acquisitions and partnerships drives strong performance and expansion.USPH
2024 Southwest IDEAS Conference13 Jan 2026 - Record revenue and patient growth drive higher earnings and positive 2025 outlook.USPH
Q4 202430 Dec 2025 - Board recommends electing eight directors, approving executive pay, and ratifying auditor.USPH
Proxy Filing1 Dec 2025 - Record Q2 growth, raised 2025 guidance, and capital returns highlight strong performance.USPH
Q2 202523 Nov 2025 - Record Q1 revenue and earnings growth driven by acquisitions and strong patient volume.USPH
Q1 202519 Nov 2025